Photo Rounds

Painful lumps in the axilla

Author and Disclosure Information

 

References

Diagnosis: Hidradenitis suppurativa

The characteristic location and morphology of the lesions, along with the chronicity and odor, were critical in arriving at a diagnosis of hidradenitis suppurativa (HS).

HS is a chronic, inflammatory skin condition that normally manifests in areas of apocrine sweat glands, including the axilla, groin, and perianal, perineal, and inframammary locations.1 It begins when an abnormal hair follicle gets occluded and ruptures, spilling keratin and bacteria into the dermis. An inflammatory response can ensue with surrounding neutrophils and lymphocytes, which leads to abscess formation and destruction of the pilosebaceous unit. Sinus tracts form between the lesions, and a cycle of scarring, fistulas, and contractures can occur.

In this case, the comedones from acne conglobata on the patient’s back indicated a more global follicular occlusion disorder. The characteristic triad is hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp—of which the patient had 2.

Even when surgical excisions are performed, medical treatment is needed to prevent new lesions and recurrences.

Other potential causes of the pathology include abnormal secretion of apocrine glands, abnormal antimicrobial peptides, deficient numbers of sebaceous glands, and abnormal invaginations of the epidermis.2 Increased levels of tumor necrosis factor alpha and other cytokines have been detected in HS lesions and are a potential target for therapy.

The prevalence of HS in the United States is approximately 0.1%.3 The condition typically begins between the ages of 18 and 39 years. The ratio of women to men affected by the condition is 3:1.2 There is no evident racial or ethnic predilection. There is an association with diabetes and Crohn disease.3 Obesity and smoking are risk factors.1

Continue to: The differential includes an array of common skin conditions

Pages

Recommended Reading

FDA issues warning about use of dermal fillers with needle-free devices
MDedge Family Medicine
PDT for actinic keratoses continues to be refined
MDedge Family Medicine
Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findings
MDedge Family Medicine
9-step ladder may kids with allergies return to eggs
MDedge Family Medicine
FDA OKs iPLEDGE change for gender-neutral language
MDedge Family Medicine
Fecal microbiota transplants may improve resistance to melanoma immunotherapy
MDedge Family Medicine
Itchy vesicles
MDedge Family Medicine
European agency supports marketing of abrocitinib for atopic dermatitis
MDedge Family Medicine
Adalimumab biosimilar Cyltezo gets interchangeability designation
MDedge Family Medicine
‘Multimorbidity’ more commonly seen in people with lupus
MDedge Family Medicine